Screening for illicit heroin use in patients in a heroin-assisted treatment program

Journal of Analytical Toxicology

Volumn 30, Issue 6, 2006, Pages 390-394

  Rook, Elisabeth J ^a   Huitema, Alwin D R ^a   Van Den Brink, Wim ^b,c   Hillebrand, Michel J X ^a   Van Ree, Jan M ^b,d   Beijnen, Jos H ^a,e  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b Central Committee on the Treatment of Heroin Addicts   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCODEINE; ALCOHOL; COCAINE; CODEINE; DIAMORPHINE; METHADONE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 ACETATE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; HEALTH PROGRAM; HEROIN DEPENDENCE; HUMAN; INTERVIEW; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; QUANTITATIVE ANALYSIS; SCREENING TEST; TANDEM MASS SPECTROMETRY;

EID: 33747666825     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/30.6.390     Document Type: Article

References (13)

1. W. van den Brink, V.M. Hendriks, P. Blanken, M.W. Koeter, B.J. van Zwieten, and J.M. Van Ree. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. Br. Med. J. 327: 310-315 (2003).
2. B. Fischer, J. Rehm, M. Kirst, M. Casas, W. Hall, M. Krausz, N. Metrebian, J. Reggers, A. Uchtenhagen, B.W. van den Brink, and J.M Van Ree. Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur. J. Public Health 12: 228-234 (2002).
3. R. Brenneisen, F. Hasler, and D. Wursch. Acetylcodeine as a urinary marker to differentiate the use of street heroin and pharmaceutical heroin. J. Anal. Toxicol. 26: 561-566 (2002).
4. C. Staub, M. Marset, A. Mino, and P. Mangin. Detection of acetylcodeine in urine as an indicator of illicit heroin use: method validation and results of a pilot study. Clin. Chem. 47: 301-307 (2001).
5. M.J. Bogusz, R.D. Maier, M. Erkens, and U. Kohls. Detection of non-prescription heroin markers in urine with liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J. Anal. Toxicol. 25: 431-438 (2001).
6. N. McLachlan-Troup, G.W. Taylor, and B.C. Trathen. Diamorphine treatment for opiate dependence: putative markers of concomitant heroin misuse. Addict. Biol. 6: 223-231 (2001).
7. M.G. Klous, B. Nuijen, B.W. van den Brink, J.M. Van Ree, and J.H. Beijnen. Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochloride. PDA J. Pharm. Sci. Technol. 58: 287-295 (2004).
8. M.G. Klous, B. Nuijen, B.W. van den Brink, J.M. Van Ree, and J.H. Beijnen. Development and manufacture of diacetylmorphine/caffeine sachets for inhalation via 'chasing the dragon' by heroin addicts. Drug Dev. Ind. Pharm. 30: 775-784 (2004).
9. E.J. Rook, M.J. Hillebrand, H. Rosing, J.M. Van Ree, and J.H. Beijnen. The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. B 824: 213-221 (2005).
10. Central Committee on the Treatment of Heroin Addicts (CCBH). Medical co-prescription of heroin. Two randomised trials. http://www.ccbh.nl/ENG/index. htm. Accessed August 2005.
11. C.E. Inturrisi, M.B. Max, K.M. Foley, M. Schultz, S.U. Shin, and R.W. Houde. The pharmacokinetics of heroin in patients with chronic pain. N. Engl. J. Med. 310: 1213-1217 (1984).
12. T.B. Vree and C.P. Verwey-van Wissen. Pharmacokinetics and metabolism of codeine in humans. Biopharm. Drug Dispos. 13: 445-460 (1992).
13. R. Brenneisen and F. Hasler. GC/MS determination of pyrolysis products from diacetylmorphine and adulterants of street heroin samples. J. Forensic Sci. 47: 885-888 (2002).